Product
Homepage
/
/
Drug Products
/
Central nervous system drugs Local anesthetics
/
Lidocaine Hydrochloride Injection 5ml: 0.1g

Drug Products

Aceglutamide Injection 2ml: 100mg
Aceglutamide Injection 2ml: 100mg
Aceglutamide Injection 2ml: 100mg
【Drug Name】
 Generic Name: Aceglutamide Injection
【Strength】
 2 mL: 100 mg
More 白箭头 黑箭头
Clindamycin Phosphate Injection 2ml: 0.3g
Clindamycin Phosphate Injection 2ml: 0.3g
Clindamycin Phosphate Injection 2ml: 0.3g
【Drug Name】
 Generic Name: Clindamycin Phosphate Injection
【Strength】
 2ml: 0.3g
More 白箭头 黑箭头
Clindamycin Phosphate Injection 4ml: 0.6g
Clindamycin Phosphate Injection 4ml: 0.6g
Clindamycin Phosphate Injection 4ml: 0.6g
【Drug Name】
 Generic Name: Clindamycin Phosphate Injection
【Strength】
 4ml: 0.6g
More 白箭头 黑箭头
Lappaconitine Hydrobromide Injection 2ml: 4mg
Lappaconitine Hydrobromide Injection 2ml: 4mg
Lappaconitine Hydrobromide Injection 2ml: 4mg
【Drug Name】
 Generic Name: Lappaconitine Hydrobromide Injection
【Strength】
 2ml: 4mg
More 白箭头 黑箭头
Levofloxacin hydrochloride Injection 5ml: 0.3g
Levofloxacin hydrochloride Injection 5ml: 0.3g
Levofloxacin hydrochloride Injection 5ml: 0.3g
【Drug Name】
 Generic Name: Levofloxacin Hydrochloride Injection
【Strength】
 5ml: 0.3g
More 白箭头 黑箭头
Levofloxacin Hydrochloride Injection 5ml: 0.5g
Levofloxacin Hydrochloride Injection 5ml: 0.5g
Levofloxacin Hydrochloride Injection 5ml: 0.5g
【Drug Name】
 Generic Name: Levofloxacin Hydrochloride Injection
【Strength】
 5ml: 0.5g
More 白箭头 黑箭头
Lidocaine Hydrochloride Injection 5ml: 0.1g
Lidocaine Hydrochloride Injection 5ml: 0.1g
Lidocaine Hydrochloride Injection 5ml: 0.1g
【Drug Name】
 Generic Name: Lidocaine Hydrochloride Injection
【Strength】
 5ml: 0.1g 
More 白箭头 黑箭头
Matrine Injection 5ml: 0.6g
Matrine Injection 5ml: 0.6g
Matrine Injection 5ml: 0.6g
【Drug Name】
 Generic Name: Matrine Injection
【Strength】
 5ml: 0.6g
More 白箭头 黑箭头
Olopatadine Hydrochloride Eye Drops 0.1% (5 ml: 5 mg)
Olopatadine Hydrochloride Eye Drops 0.1% (5 ml: 5 mg)
Olopatadine Hydrochloride Eye Drops 0.1% (5 ml: 5 mg)
【Drug Name】
 Generic Name: Olopatadine Hydrochloride Eye Drops
【Strength】
 0.1% (5 ml: 5 mg)
More 白箭头 黑箭头
Prochlorperazine Edisylate Injection 5 mg/mL (2 mL)
Prochlorperazine Edisylate Injection 5 mg/mL (2 mL)
Prochlorperazine Edisylate Injection 5 mg/mL (2 mL)
【Drug Name】
 Generic Name: Prochlorperazine Edisylate Injection
【Strength】
 5 mg/mL (2 mL)
More 白箭头 黑箭头
Propylgallate Injection 5ml: 60mg
Propylgallate Injection 5ml: 60mg
Propylgallate Injection 5ml: 60mg
【Drug Name】
 Generic Name: Propylgallate Injection
【Strength】
 5ml: 60mg
More 白箭头 黑箭头
Puerarin Injection 5ml: 0.25g
Puerarin Injection 5ml: 0.25g
Puerarin Injection 5ml: 0.25g
【Drug Name】
 Generic Name: Puerarin Injection
【Strength】
 5ml: 0.25g
More 白箭头 黑箭头
Puerarin Injection 8ml: 0.4g
Puerarin Injection 8ml: 0.4g
Puerarin Injection 8ml: 0.4g
【Drug Name】
 Generic Name: Puerarin Injection
【Strength】
 8ml: 0.4g
More 白箭头 黑箭头
Varenicline Tablets 0.5mg
Varenicline Tablets 0.5mg
Varenicline Tablets 0.5mg
【Drug Name】
 Generic Name: Varenicline Tablets
【Strength】
 0.5 mg
More 白箭头 黑箭头
Varenicline Tablets 1.0mg
Varenicline Tablets 1.0mg
Varenicline Tablets 1.0mg
【Drug Name】
 Generic Name: Varenicline Tablets
【Strength】
 1.0 mg
More 白箭头 黑箭头
Vitamin B12 Injection 1 mL: 0.25 mg
Vitamin B12 Injection 1 mL: 0.25 mg
Vitamin B12 Injection 1 mL: 0.25 mg
【Drug Name】
 Generic Name: Vitamin B12 Injection
【Strength】
 1 mL: 0.25 mg
More 白箭头 黑箭头
Vitamin B12 Injection 1 mL: 0.5 mg
Vitamin B12 Injection 1 mL: 0.5 mg
Vitamin B12 Injection 1 mL: 0.5 mg
【Drug Name】
 Generic Name: Vitamin B12 Injection
【Strength】
 1 mL: 0.5mg
More 白箭头 黑箭头
Previous page
1

Drug Products

CLASSIFICATION

News Center

Viwit’s Levetiracetam Tablets Approved by FDA 2024-04-09 11:28:41
On April 5, 2024, Viwit Pharmaceuticals' Levetiracetam Tablets received an Approval Letter (#078869) from the U.S. Food and Drug Administration (FDA), marking Viwit's first approved oral solid dosage in the United States.
Viwit Pharmaceuticals' Mirabegron API Receives Official Approval by China NMPA 2024-01-26 11:09:29
On January 23, 2024, Viwit Pharmaceuticals received the "Notice of Approval of Application for Listing of Chemical APIs" issued by China National Medical Products Administration (NMPA) for its own proprietary active pharmaceutical ingredient (API) Mirabegron, developed independently. The issued registration number is Y20220000096, and the corresponding notice number is 2024YS00039.
Viwit Pharmaceuticals' Vildagliptin Tablets Receive Official Approval by China NMPA 2023-12-22 13:19:44
Viwit Pharmaceuticals is pleased to announce the acquisition of the Drug Registration Certificate (Certificate No: 2023S01974) from the National Medical Products Administration (NMPA) for a proprietary finished dosage form, Vildagliptin tablet. This signifies the official approval of this product in the Chinese market.
Viwit Pharmaceuticals' Lidocaine Injection Receives Official Approval by China NMPA 2023-12-19 11:25:05
On December 18, 2023, Viwit Pharmaceuticals received the "Drug Supplementary Application Approval Notice" (Notice No: 2023B06224) issued by the China National Medical Products Administration for a proprietary finished dosage form, Lidocaine Hydrochloride for Injection (5ml: 0.1g).
Viwit Pharmaceuticals' Vildagliptin API Receives Official Approval by China NMPA 2023-12-07 08:31:28
On November 30, 2023, Viwit Pharmaceuticals received the "Notice of Approval of Application for Listing of Chemical APIs" issued by National Medical Products Administration (NMPA) for its independently developed active pharmaceutical ingredient (API), Vildagliptin. The registration number is Y20210000619, and the notice number is 2023YS00803.
Viwit Pharmaceuticals' Aprepitant API Receives Official Approval by China NMPA 2023-10-31 15:33:57
On October 26, 2023, Viwit Pharmaceuticals received the "Notice of Approval of Application for Listing of Chemical APIs" issued by China National Medical Products Administration (NMPA) for the independently developed active pharmaceutical ingredient (API) Aprepitant. The registration number is Y20210000473, and the notice number is 2023YS00727.

Lidocaine Hydrochloride Injection 5ml: 0.1g

【Drug Name】
 Generic Name: Lidocaine Hydrochloride Injection
【Strength】
 5ml: 0.1g 
Product Name : Lidocaine Hydrochloride Injection
CAS# :
lD79FW6hRrmaUQd7VB5f0A
EVDxIIQqSuahfp80iHD0Fg
产品描述
Parameters

【Drug Name】

Generic Name：Lidocaine Hydrochloride Injection

【Strength】

5ml: 0.1g 

【Approval Status】

NMPA approval No.: H37022962

【Indication】

Local anesthetics and antiarrhythmic drugs. It is mainly for infiltration anesthesia, epidural anesthesia, surface anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery), and nerve conduction block. This product can be used for ventricular premature beats and ventricular tachycardia after acute myocardial infarction. It can also be used for digitalis poisoning, cardiac surgery, and ventricular arrhythmias caused by cardiac catheterization. This product is usually ineffective for supraventricular arrhythmias.

Refers to drug instructions for details.

 

Scan the QR code to read on your phone
We could not find any corresponding parameters, please add them to the properties table
Previous
None
Next
Aceglutamide Injection 2ml: 100mg
search
Confirm
Close
About Us
Company Introduction Corporate History Business Introduction Corporate Governance Company Culture Corporate Honors Viwit Family Media Center Video
R&D and Innovation
R&D Innovation Product Pipeline Achievements
Products
Drug Products Biologics APIs Intermediates Boranes
Innovation
CDMO Project Collaboration In-/Out-Licensing Joint Venture
Sustainable
EHS Energy Quality Supplier
News Center
In 2024 In 2023 In 2022 In 2021 In 2020 In 2019 In 2018 In 2017 In 2016
Join Us
Talent Philosophy Talent Development Salary and Benefits Campus Recruiting Social Recruitment
Contact Us
Online Message Contact Us
News Center
dp EN
dp 中文

wz

wz